Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03164395 · ClinicalTrials.gov registry record · NA
The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Atrial Fibrillation
A NA study, sponsored by University of Kentucky.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT03164395: Completed NA study, sponsored by University of Kentucky.
NCT03164395 is a NA study that has completed, run by University of Kentucky. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03164395, a NA study, has completed, sponsored by University of Kentucky.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study seeks to determine the efficacy of single coil defibrillation leads for cardioversion of persistent atrial fibrillation.
Primary Outcome
Does the patient return for at least one beat to sinus rhythm following the administration of a shock
Interventions
- PROCEDURE Internal Cardioversion
- PROCEDURE External Cardioversion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2018-10-23 |
| Phase | NA |
What the finished NCT03164395 record still lists
NCT03164395 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Internal Cardioversion is the first listed.
NCT03164395 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03164395 about?
NCT03164395 is a clinical study titled "The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Atrial Fibrillation". This study seeks to determine the efficacy of single coil defibrillation leads for cardioversion of persistent atrial fibrillation.
What is the current status of trial NCT03164395?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2017-07-01. Estimated completion is 2018-10-23.
What interventions are being tested in trial NCT03164395?
The interventions under investigation include: Internal Cardioversion (PROCEDURE), External Cardioversion (PROCEDURE).
Who is sponsoring clinical trial NCT03164395?
This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03164395's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI